雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Bisphosphonate (Alendronate): Induced Esophagitis Observed by Endoscopy, Report of a Case Yoshiyuki Ito 1 , Yukiko Kuroda 1 , Takashi Uchiyama 1 , Takaya Saito 1 , Shigeji Ito 1 , Yasuharu Kaizaki 2 1Division of Internal Medicine, Tannan Regional Medical Center, Sabae, Japan 2)Department of Pathology, Fukui Prefectural Hospital, Fukui, Japan Keyword: 薬剤性食道炎 , ビスフォスフォネート製剤 , 服薬指導 pp.193-197
Published Date 2015/2/25
DOI https://doi.org/10.11477/mf.1403200151

閲覧方法のご案内

この論文を閲覧するためにはログインが必要になります。
パスワードを忘れた場合 新しくユーザー登録する 施設共通IDをご利用の方はこちらから

PPV購入案内

1,320円 (1,200円+税10%) こちらは、193ページから197ページの文献です。
PPV(ペイ・パー・ビュー)とは、論文(記事)単位で購入・閲覧ができるサービスです。
購入には医書.jp本会員登録が必要です。



会員登録完了後に改めて上記「購入サイトへ」を選択してください。
または「購入サイトへ」選択後に「購入ログイン」、「新規会員登録」の順に進んでください。

会員登録について詳しくはをご確認ください。
  • Abstract
  • Look Inside
  • Reference
  • Cited by

 A 69-year-old woman was admitted to our hospital because of severe retrosternal pain, odynophagia, heartburn, and body weight loss. She had been generally well until a week before admission. Endoscopic examination revealed demarcated shallow esophageal erosions at 30〜35 cm from the incisors, with normal adjacent mucosa. Pathological examination of the biopsy specimen showed inflammatory exudates and inflamed granulation tissue accompanied with massive eosinophilic infiltration. The patient reported receiving alendronate for 3 years as a treatment for post-menopausal osteoporosis and had taken the tablet without adequate water 4 days before onset. Therefore, erosions were believed to be because of alendronate intake, and alendronate-induced esophagitis was diagnosed. All symptoms had immediately resolved by a temporary period parenteral hydration and administration of intravenous H2-receptor antagonist and oral antacids. Ten days after admission, repeated endoscopic examination demonstrated ulcer healing. It is important to perform endoscopy immediately for accurate diagnosis. Moreover, we would like to emphasize the importance of providing proper instructions to minimize the risk of serious side effects of bisphosphonates.


Copyright © 2015, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1219 印刷版ISSN 0536-2180 医学書院

関連文献

もっと見る

文献を共有